华北制药财务报表 |
评论“华北制药” |
|
|
项目 |
2004年 |
2003年 |
2002年 |
货币资金 |
641,205,312.00 |
448,780,832.00 |
543,088,704.00 |
短期投资 |
0.00 |
0.00 |
0.00 |
减:短期投资跌价准备 |
0.00 |
0.00 |
0.00 |
短期投资净额 |
0.00 |
0.00 |
0.00 |
应收票据 |
272,579,552.00 |
330,316,672.00 |
141,102,768.00 |
应收股利 |
116,914.67 |
116,914.67 |
2,611,703.50 |
应收利息 |
0.00 |
0.00 |
0.00 |
应收帐款 |
1,341,017,856.00 |
1,231,751,552.00 |
1,183,667,072.00 |
减:坏帐准备 |
0.00 |
0.00 |
0.00 |
应收帐款净额 |
0.00 |
0.00 |
0.00 |
预付帐款 |
95,427,336.00 |
70,243,344.00 |
50,688,440.00 |
应收补帖款 |
12,658,894.00 |
14,559,232.00 |
64,617,556.00 |
其它应收款 |
660,558,080.00 |
1,186,288,256.00 |
1,239,053,696.00 |
存货 |
998,009,088.00 |
584,838,208.00 |
514,627,264.00 |
减:存货跌价准备 |
0.00 |
0.00 |
0.00 |
存货净额 |
998,009,088.00 |
584,838,208.00 |
514,627,264.00 |
待摊费用 |
4,618,628.50 |
4,658,292.00 |
3,165,394.25 |
待处理流动资产净损失 |
0.00 |
0.00 |
0.00 |
一年内到期的长期流动资产净损失 |
|
|
|
其它流动资产 |
0.00 |
0.00 |
0.00 |
流动资产合计 |
4,029,321,472.00 |
3,871,553,280.00 |
3,770,902,528.00 |
中长期贷款 |
|
|
|
逾期贷款 |
|
|
|
减贷款呆帐准备 |
|
|
|
长期股权投资 |
349,714,912.00 |
428,490,944.00 |
451,761,056.00 |
长期债权投资 |
7,000,000.00 |
37,010,000.00 |
83,010,000.00 |
长期投资合计 |
356,714,912.00 |
472,719,520.00 |
534,771,040.00 |
减:长期投资减值准备(相当投资风险准备) |
0.00 |
0.00 |
0.00 |
长期投资净额(或长期资产、投资合计) |
0.00 |
0.00 |
0.00 |
固定资产原价 |
5,002,316,800.00 |
4,241,838,336.00 |
3,880,315,904.00 |
减:累计折旧 |
1,995,439,104.00 |
1,767,299,968.00 |
1,508,689,408.00 |
固定资产净值 |
3,006,877,696.00 |
2,474,538,240.00 |
2,371,626,496.00 |
工程物资 |
86,741.53 |
117,005.80 |
209,151.73 |
在建工程 |
137,111,904.00 |
384,006,592.00 |
208,849,552.00 |
固定资产清理 |
0.00 |
282,566.66 |
181,566.20 |
待处理固定资产净损失 |
0.00 |
0.00 |
0.00 |
固定资产合计 |
3,086,946,560.00 |
2,799,447,296.00 |
2,520,213,760.00 |
无形资产 |
119,761,544.00 |
106,700,312.00 |
110,565,904.00 |
开办费 |
0.00 |
0.00 |
0.00 |
长期待摊费用 |
15,346,651.00 |
14,184,237.00 |
9,813,218.00 |
其它长期资产 |
0.00 |
0.00 |
0.00 |
无形资产及其它资产合计 |
135,108,192.00 |
120,884,552.00 |
120,379,128.00 |
递延税款借项 |
0.00 |
0.00 |
0.00 |
资产总计 |
7,611,586,048.00 |
7,264,604,672.00 |
6,958,987,264.00 |
短期借款 |
3,269,092,096.00 |
2,474,449,920.00 |
2,475,599,872.00 |
应付票据 |
396,440,928.00 |
233,970,896.00 |
152,245,616.00 |
应付帐款 |
821,669,440.00 |
667,987,968.00 |
541,380,672.00 |
预收帐款 |
98,187,584.00 |
52,086,016.00 |
45,121,428.00 |
代销商品款 |
0.00 |
0.00 |
0.00 |
应付工资 |
20,099,574.00 |
32,751,302.00 |
33,645,524.00 |
应付福利费 |
113,750,624.00 |
110,273,192.00 |
87,518,896.00 |
应付股利 |
46,260,320.00 |
69,399,928.00 |
89,064,208.00 |
应交税金 |
492,154.41 |
-35,079,140.00 |
11,963,285.00 |
其他应交款 |
14,590,534.00 |
7,125,868.00 |
8,714,520.00 |
其他应付款 |
332,237,440.00 |
189,015,872.00 |
115,645,728.00 |
预提费用 |
3,541,305.00 |
7,613,163.50 |
7,631,874.50 |
一年内到期的长期负债 |
30,000,000.00 |
627,000,000.00 |
497,500,000.00 |
其他流动负债 |
0.00 |
0.00 |
0.00 |
流动负债合计 |
5,146,361,856.00 |
4,436,595,200.00 |
4,066,031,872.00 |
长期借款 |
725,000,000.00 |
53,500,000.00 |
202,920,000.00 |
应付债券 |
0.00 |
0.00 |
0.00 |
长期应付款 |
14,415,491.00 |
16,415,491.00 |
18,636,492.00 |
住房周转金 |
0.00 |
0.00 |
0.00 |
其他长期负债 |
0.00 |
0.00 |
0.00 |
长期负债合计 |
745,395,520.00 |
72,715,488.00 |
225,156,496.00 |
递延税款贷项 |
0.00 |
0.00 |
0.00 |
负债合计 |
5,891,757,568.00 |
4,509,310,464.00 |
4,291,188,224.00 |
少数股东权益 |
200,867,392.00 |
247,057,504.00 |
217,647,312.00 |
股本 |
761,909,312.00 |
1,169,394,176.00 |
1,169,394,176.00 |
资本公积金 |
508,010,336.00 |
1,095,338,624.00 |
1,087,560,960.00 |
盈余公积金 |
433,230,816.00 |
405,550,464.00 |
322,585,664.00 |
其中公益金 |
68,646,512.00 |
35,081,824.00 |
59,930,116.00 |
未分配利润 |
-184,189,280.00 |
-162,046,704.00 |
-129,389,072.00 |
股东权益合计 |
1,518,961,152.00 |
2,508,236,544.00 |
2,450,151,680.00 |
负债和股东权益合计 |
7,611,586,048.00 |
7,264,604,672.00 |
6,958,987,264.00 |
|